All terms in MeSH

Label Id Description
Receptors, Interferon D12.776.543.750.705.852.400
Vascular Ring C16.131.240.850.984
RNA, Small Nuclear D13.444.735.790.552.937
Rhodopsins, Microbial D12.776.752.812
Photoreceptors, Microbial D12.776.752
Carbohydrate Metabolism D050260 [Cellular processes in biosynthesis (anabolism) and degradation (catabolism) of CARBOHYDRATES. ]
Glycogenolysis D050261 [The release of GLUCOSE from GLYCOGEN by GLYCOGEN PHOSPHORYLASE (phosphorolysis). The released glucose-1-phosphate is then converted to GLUCOSE-6-PHOSPHATE by PHOSPHOGLUCOMUTASE before entering GLYCOLYSIS. Glycogenolysis is stimulated by GLUCAGON or EPINEPHRINE via the activation of PHOSPHORYLASE KINASE. ]
Loma D050262 [A genus of FUNGI, in the family Glugeidae, a parasite of ATLANTIC SALMON and other FISHES. ]
Adenovirus E1B Proteins D23.050.327.062.050
Antigens, Viral, Tumor D23.050.327.062
Thelohania D050263 [A genus of FUNGI, in the family Thelohaniidae, a parasite of red imported fire ants, MOSQUITOES, and other organisms. ]
Trophoblasts A16.254.500.766
Blastocyst A16.254.500
SAIDS Vaccines D20.215.894.899.790
Pregnancy Rate N06.850.505.400.975.775
Vital Statistics N06.850.505.400.975
Nasal Septal Perforation C08.460.595
Clonal Hematopoiesis D000082182 [Expansion of blood cells arising from mutant HEMATOPOIETIC STEM CELLS often related to aging. Mutations on epigenetic regulator genes are common in clonal hematopoiesis and may be a risk factor for HEMATOLOGIC NEOPLASMS and other cardiovascular diseases. When variant allele fraction is at least 2% and is present in the absence of severe cytopenias it is referred to as clonal hematopoiesis of indeterminate potential (CHIP). ]
G(M2) Activator Protein D049289 [An essential cofactor for the degradation of G(M2)GANGLIOSIDE by lysosomal BETA-N-ACETYLHEXOSAMINIDASES. Genetic mutations resulting in loss of G(M2) activator protein are one of the causes of TAY-SACHS DISEASE, AB VARIANT. ]
Microvascular Angina C14.907.585.187.575